During the last session, RAPT Therapeutics Inc (NASDAQ:RAPT)’s traded shares were 0.11 million, with the beta value of the company hitting -0.14. At the end of the trading day, the stock’s price was $7.42, reflecting an intraday loss of -5.36% or -$0.42. The 52-week high for the RAPT share is $30.60, that puts it down -312.4 from that peak though still a striking 23.58% gain since the share price plummeted to a 52-week low of $5.67. The company’s market capitalization is $122.70M, and the average trade volume was 117.92K shares over the past three months.
RAPT Therapeutics Inc (RAPT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.20. RAPT has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
RAPT Therapeutics Inc (RAPT) registered a -5.36% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.36% in intraday trading to $7.42, hitting a weekly high. The stock’s 5-day price performance is -15.68%, and it has moved by -4.17% in 30 days. Based on these gigs, the overall price performance for the year is -72.06%.
The consensus price target of analysts on Wall Street is $33, which implies an increase of 77.52% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $55 respectively. As a result, RAPT is trading at a discount of -641.24% off the target high and 73.05% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -10.10%. While earnings are projected to return 87.35% in 2025, the next five years will return 46.70% per annum.
RAPT Dividends
RAPT Therapeutics Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 3.11 million shares, is of VANGUARD GROUP INC’s that is approximately 7.9972% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.48 million.
